SEARCH

SEARCH BY CITATION

References

  • 1
    Busing M, Martin D, Riege R, et al. Combined pancreas/kidney transplantation as standard procedure in therapy of type I diabetic patients in renal failure. Chirurg 1996; 67:1002.
  • 2
    Pratschke J, Wilhelm MJ, Kusaka M, et al. Brain death and its influence on donor organ quality and outcome after transplantation. Transplantation 1999; 67:343.
  • 3
    Benz S, Schnabel R, Morgenroth K, et al. Ischemia/reperfusion injury of the pancreas: a new animal model. J Surg Res 1998; 75:109.
  • 4
    Obermaier R, Benz S, Kortmann B, et al. Ischemia/reperfusion induced pancreatitis in rats: a new model of complete normothermic in situ ischemia of a pancreatic tail segment. Clin Exp Med 2001; 1:51.
  • 5
    Benz S, Pfeffer F, Buesing M, et al. Lokale- und systemische Komplikationen nach kombinierter Nieren/-Pankreas Transplantation. Chir Gastroenterol 1996; 12 (suppl).
  • 6
    Grewal HP, Garland L, Novak K, et al. Risk factors for post-implantation pancreatitis and pancreatic thrombosis in pancreas transplant recipients. Transplantation 1993; 56:609.
  • 7
    Benz S, Obemaier R, Wiessner R, et al. Effect of nitric oxide in ischemia/reperfusion of the pancreas. J Surg Res 2002; 106:46.
  • 8
    Obermaier R, Benz S, von Dobschuelz E, et al. Characterisation of microcir-culatory disturbance in a novel model of pancreatic ischemia-reperfusion using intravital fluorescence-microscopy. Pancreas 2002; 25:142.
  • 9
    Benz S, Pfeffer F, Adam U, et al. Impairment of pancreatic microcirculation in the early reperfusion period during simultaneous pancreas-kidney transplantation. Transpl Int 1998; 11 Suppl 1:433.
  • 10
    Benz S, Bergt S, Obermaier R, et al. Impairment of microcirculation in the early reperfusion period predicts the degree of graft pancreatitis in clinical pancreas transplantation. Transplantation 2001; 71:759.
  • 11
    Benz S, Wiessner R, Obermaier R, et al. Microcirculatory events in ischemia/reperfusion injury defined by continuous tissue oximetry. Transpl Int 2002; 15:173.
  • 12
    Heemann U, Szabo A, Hamar P, et al. Lipopolysaccharide pretreatment protects from renal ischemia/reperfusion injury: possible connection to an interleukin-6-dependent pathway. Am J Pathol 2000; 156:287.
  • 13
    Sakorafas GH, Tsiotos GG, Sarr MG. Ischemia/reperfusion-induced pancreatitis. Dig Surg 2000; 17:3.
  • 14
    Moncada S, Radomski MW, Palmer RM. Endothelium-derived relaxing factor, identification as nitric oxide and role in the control of vascular tone and platelet function. Biochem Pharmacol 1988; 37:2495.
  • 15
    Moilanen E, Vuorinen P, Kankaanranta H, et al. Inhibition by nitric oxide donors of human polymorphonuclear leucocyte functions. Br J Pharmacol 1993; 109:852.
  • 16
    Radomski MW, Palmer RM, Moncada S. Modulation of platelet aggregation by anL-arginine-nitric oxide pathway. Trends Pharmacol Sci. 1991; 12:87.
  • 17
    Bosca L, Hortelano S. Mechanisms of nitric oxide-dependent apoptosis: involvement of mitochondrial mediators. Cell Signal 1999; 11:239.
  • 18
    Molero X, Guarner F, Salas A, et al. Nitric oxide modulates pancreatic basal secretion and response to cerulein in the rat: effects in acute pancreatitis. Gastroenterol 1995; 108:1855.
  • 19
    Hoffmann TF, Uhl E, Messmer K. Protective effect of the somatostatin analogue octreotide in ischemia/reperfusion-induced acute pancreatitis in rats. Pancreas 1996; 12:286.
  • 20
    Kubes P, Kurose I, Granger DN. NO donors prevent integrin-induced leukocyte adhesion but not p-selectin-dependent rolling in post-ischemic venules. Am J Physiol 1994; 267:H931.
  • 21
    Cristol JP, Thiemermann C, Guerin MC, et al. L-arginine infusion after ischaemia-reperfusion of rat kidney enhances lipid peroxidation. J Lipid Mediat Cell Signal 1996; 13:9.
  • 22
    Tome LA, Yu L, de Castro I, et al. Beneficial and harmful effects ofL-arginine on renal ischaemia. Nephrol Dial Transplant 1999; 14:1139.
  • 23
    Lopez-Neblina F, Paez AJ, Toledo-Pereyra LH. Modulation of neutrophil infiltration through nitric oxide in the ischemic rat kidney. Transplant Proc 1995; 27:1883.
  • 24
    Liu P, Xu B, Hock CE, et al. NO modulates P-selectin and ICAM-1 mRNA expression and hemodynamic alterations in hepatic I/R. Am J Physiol 1998; 275:H2191.
  • 25
    Amrani M, Chester AH, Jayakumar J, et al. L-arginine reverses low coronary reflow and enhances post-ischaemic recovery of cardiac mechanical function. Cardiovasc Res 1995; 30:200.
  • 26
    Takeuchi K, McGowan FX, Danh HC, et al. Direct detrimental effects ofL-arginine upon ischemia- reperfusion injury to myocardium. J Mol Cell Cardiol 1995; 27:1405.
  • 27
    Verrecchia C, Boulu RG, Plotkine M. Neuroprotective and deleterious effects of nitric oxide on focal cerebral ischemia-induced neurone death. Adv Neuroimmunol 1995; 5:359.
  • 28
    Vollmar B, Janata J, Yamauchi JI, et al. Attenuation of microvascular reperfusion injury in rat pancreas transplantation byL-arginine. Transplantation 1999; 67:950.
  • 29
    Benz S, Schnabel R, Weber H, et al. The nitric oxide donor sodium nitroprusside is protective in ischemia/reperfusion injury of the pancreas. Transplantation 1998; 66:994.
  • 30
    Werner J, Rivera J, Fernandez-del Castillo C, et al. Differing roles of nitric oxide in the pathogenesis of acute edematous versus necrotizing pancreatitis. Surgery 1997; 121:23.
  • 31
    Hotter G, Closa D, Pi F, et al. Nitric oxide and arachidonate metabolism in ischemia-reperfusion associated with pancreas transplantation. Transplantation 1995; 59:417.
  • 32
    Tanaka S, Kamiike W, Kosaka H, et al. Detection of nitric oxide production and its role in pancreatic ischemia-reperfusion in rats. Am J Physiol 1996; 271:G405.
  • 33
    Nolte D, Messmer K. Tissue protection by anti-ischemic drugs. Minerva Cardioangiol 1995; 43:485.
  • 34
    Klar E, Endrich B, Messmer K. Microcirculation of the pancreas: a quantitative study of physiology and changes in pancreatitis. Int J Microcirc Clin Exp 1990; 9:85.
  • 35
    Benz S, Bergt S, Pfeffer F, et al. Pathophysiologische Veränderungen in der frühen Reperfusionsphase humaner Pankreastransplantate. Transplanta-tionsmedizin 1999; 11:41.
  • 36
    Büsing M. Morphologie und Pathophysiologie der Transplantatpankreatitis nach kombinierter Pankreasduodenal-/Nierentransplantation. Habilitationsschrift, Ruhr Universität, Bochum 1994.
  • 37
    Zimmermann C, Haberl RL. L-arginine improves diminished cerebral CO2 reactivity in patients. Stroke 2003; 34:643.